7.50
+0.03
+(0.43%)
At close: January 31 at 8:00:44 AM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 8 | 8 |
| Avg. Estimate | 46.05M | 46.42M | 177.57M | 210.61M |
| Low Estimate | 43M | 42.49M | 174M | 204M |
| High Estimate | 48M | 48.88M | 179.63M | 217.82M |
| Year Ago Sales | 45.78M | 41.87M | 170.28M | 177.57M |
| Sales Growth (year/est) | 0.58% | 10.87% | 4.28% | 18.61% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 1HM.MU | -- | -- | -- | -- |
| S&P 500 | 9.91% | 10.33% | 14.01% | 13.75% |
Upgrades & Downgrades
| Maintains | Goldman Sachs: Neutral to Neutral | 1/28/2025 |
| Maintains | BTIG: Buy to Buy | 12/18/2024 |
| Maintains | Piper Sandler: Overweight to Overweight | 11/11/2024 |
| Maintains | BTIG: Buy to Buy | 10/2/2024 |
| Maintains | JP Morgan: Overweight to Overweight | 8/2/2024 |
| Maintains | JP Morgan: Overweight to Overweight | 5/8/2024 |
Related Tickers
RGO.F Regeneron Pharmaceuticals, Inc.
655.40
-0.21%
REGN34.SA Regeneron Pharmaceuticals, Inc.
65.74
-1.81%
1MRNA.MI Moderna, Inc.
39.44
-2.13%
BEAM Beam Therapeutics Inc.
25.92
-4.99%
SANA Sana Biotechnology, Inc.
3.2200
-7.74%
DNA Ginkgo Bioworks Holdings, Inc.
13.36
-3.95%
DWTX Dogwood Therapeutics, Inc.
12.49
-2.12%
CRSP CRISPR Therapeutics AG
41.59
-1.07%
AKRO Akero Therapeutics, Inc.
54.08
-2.31%
MRNA Moderna, Inc.
39.42
-3.95%